C yanoacrylate glues are liquid alkyl-2-cyanoacrylate monomers that, on contact with ionic mediums (e.g., water, blood), form flexible polymers with strong adhesive bonds to soft tissues. These liquid monomers in isolation are nonviscous, radiolucent, and rapidly polymerize. Consequently, they are combined as a two-component embolic agent with either tantalum powder or ethiodized oil. The added agent prolongs polymerization time, opacifies the liquid agent, and allows for its visualization under fluoroscopy.
With super-selective catheter delivery in a flow-directed fashion, the n-butyl-2-cyanoacrylate (n-BCA) liquid embolic system (Trufill, Cordis Neurovascular) is approved by the Food and Drug Administration (FDA) for embolization of cerebral arteriovenous malformations (AVMs) (1) . Through novel implementation, interventional radiologists have proven its safe and effective off-label use for the embolization of vascular and lymphatic pathology, arterial pseudoaneurysms, endoleaks, and vascular tumors. Because injected glue cannot be precisely controlled, the result of each deposition may be unpredictable and its use requires technical knowhow.
Procedure-related adverse events documented in prospective, randomized trials and use guidelines from the Japanese Society of Interventional Radiology fit into three categories: inadvertent vascular embolization, suboptimal agent polymerization time, and catheter retention (2) (3) (4) . This article presents a pictorial essay highlighting these complications as they were encountered during adhesive cyanoacrylate deposition and discusses primary prevention strategies and management options. safety profile, are relatively atraumatic, and are simple to use, providing good perceptual feedback. Using any one of the many purpose-designed snares, the loop is closed around the rogue fragment (Fig. 4) by advancing the catheter, and the whole system is retrieved back into the sheath (6) . If the fragment is larger than a reasonable sheath diameter and is settled in close proximity to the target lesion, relocation may be attempted. By advancing the catheter system with charge of the fragment, the embolus may be redirected back toward the target lesion. If the fragment is not stable at the newly deposited location or if a large fragment is found far from the target, it may be easier, safer, and quicker to identify a suitable vascular bed within which to safely and permanently park the glue embolus. After redirecting the adhesive fragment to a designated location, an endograft may be deployed across the embolic cast, trapping it against the vascular wall (Fig. 2) . This technique eliminates the risk of fragmentation of the n-BCA embolus and downstream vessel compromise.
Delayed polymerization causing venous migration
Embolic agent migration past the target lesion due to delayed polymerization is a well-described and serious complication during AVM embolization where blockage of venous outflow increases hemorrhage risk (7) . By similar hemodynamic tenets, occlusion of portosystemic collaterals in cirrhotic patients may be clinically significant. Partial or complete occlusion of the portal (Fig. 1) or splenic (Fig. 3 ) veins during gastroesophageal varix embolization may preclude liver transplantation and should be addressed prophylactically. Placement of venous stents may be used to ensure vessel patency (Fig. 3) .
Several factors impact the depth of glue penetration including the direction and speed of blood flow past the catheter tip, injection technique, and cyanoacrylate dilution (ratio of n-BCA to ethiodized oil).
Ethiodized oil is mixed with n-BCA in various dilution ratios depending on the application to control polymerization rate. A glue mixture with a higher proportion of n-BCA polymerizes more quickly on contact with ionic mediums and would be preferred if over-penetration were more concerning than complete lesion occlusion procedurally.
Premature polymerization
Injected n-BCA may polymerize prematurely blocking the microcatheter or refluxing around the catheter tip, poten-
Main points
• The n-butyl cyanoacrylate liquid embolic system is approved by the Food and Drug Administration for embolization of cerebral arteriovenous malformations, but is also used in the peripheral circulation for embolization of vascular and lymphatic pathology, arterial pseudoaneurysms, endoleaks, and vascular tumors.
• Despite best efforts, n-butyl cyanoacrylate glue deposition is inherently unpredictable and complications including nontarget embolization, venous migration, microcatheter blockage, and catheter retention do occur.
• An understanding of techniques used to minimize adverse events and manage complications, including embolus relocation and stent deployment, are requisite for using liquid embolic agents safely and efficiently. tially leading to retention to either the vascular wall or deployed devices, e.g., vascular plugs (Fig. 2) , endografts ( Fig. 5) , or coils. These complications generally do not have untoward clinical consequences, but should nonetheless be managed with care.
Premature polymerization causing microcatheter blockage
Premature polymerization of adhesives in the feeding pedicle is most often the result of suboptimal component mixture, delivery system use, or volume and speed of injection. Thus, avoidance is primarily a matter of preventative planning. Prior to injection of the n-BCA mixture, the microcatheter should be flushed with nonheparinized 5% dextrose (D5). This nonionic solution is used in place of a saline flush to prevent polymerization of the mixture on contact with residual blood or saline in the catheter tip (8) . Injecting dextrose also creates a local nonionic environment at the catheter tip enabling more distal n-BCA progression (8) .
Regarding injection technique, polymerization may be delayed using the flood technique. In this approach, the inner diameter of the guide catheter is sufficiently larger than the outer diameter of the microcatheter to allow for a positive-pressure continuous flush with dextrose around the microcatheter. This will create a local nonionic environment at the catheter tip, slowing glue polymerization and allowing for deeper penetration of the mixture and more distal embolization. This technique is particularly useful when embolizing around a placed device or into a bleeding artery that is difficult to reach using the current generation of microcatheters. Once the injection is complete, the microcatheter is aspirated and withdrawn rapidly.
Should the catheter become occluded, the microcatheter should be replaced. 
Premature polymerization causing catheter retention
Catheter entrapment within polymerized glue is a long-acknowledged risk associated with the use of adhesive cyanoacrylates. As primary prevention, care should be taken to remove redundant loops in the catheter to ensure the availability of quick and controlled pullback as needed. Permanent catheter fixation is less likely to occur with the use of hydrophilic-coated microcatheters given weaker n-BCA bonding and reduced catheter friction (9) . Attention should be paid to cyanoacrylate ratio and the prevention of premature polymerization as described above when injecting liquid adhesives around placed devices.
If polymerized glue refluxes around the microcatheter tip, the tip should be pulled back sufficiently to free it prior to polymerization. Should the catheter adhere to surrounding structures, avoid forceful movement of the catheter to limit soft tissue trauma. Should the microcatheter tip fracture (Fig. 5) , it may be left in place provided flow to critical structures is not compromised. Even complete microcatheters may safely remain in the vascular lumen attached to the adherent tip with the proximal end cut and left in the subcutaneous tissue (3). Fear of vessel thrombosis surrounding the retained foreign body, while perhaps an indication for catheter removal in the cerebral circulation (10) , is less clinically significant in the periphery. Here, removal depends on characteristics of the catheter location and structures involved.
Conclusion
The behavior of liquid embolic agents during deposition in a biological system can be unpredictable. Understanding strategies to prevent and manage complications are required for their safe clinical use.
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